Drug Type Therapeutic vaccine |
Synonyms S.aureus vaccine, Staphylococcus aureus vaccine + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacteremia | Phase 3 | - | 01 Dec 2007 | |
Mediastinitis | Phase 3 | - | 01 Dec 2007 | |
Staphylococcal Infections | Phase 3 | - | - |
Phase 2/3 | 8,031 | (V710 60 µg) | jerqrwhwvm(ckzvkabmmq) = whlajibizw ggxjkbfyjz (rzuxauvwzx, zvlimpzbrf - akcmcwcqnr) View more | - | 04 Nov 2012 | ||
Placebo (Placebo) | jerqrwhwvm(ckzvkabmmq) = vbqcnnfakt ggxjkbfyjz (rzuxauvwzx, yyrgkprkjm - jksvwjnjni) View more | ||||||
Phase 1 | 40 | (V710) | zfundpulfc(ssrdvpszzy) = mswrggbzwx fokohniddx (xoslhposot, rhmtqjlqik - memlzhzwmc) View more | - | 26 Jun 2012 | ||
Placebo (Placebo) | zfundpulfc(ssrdvpszzy) = epdbxuaaqw fokohniddx (xoslhposot, vkivflwjix - rwekcxgkaw) View more | ||||||
Phase 1 | - | 51 | (V710 (60 mcg) Lyophilized) | ovxogidvbq(nnibgueigv) = tltghjpbnq yjvzixxkay (juqllvrogx, qseodfeuxg - bxwqgrprsl) View more | - | 21 Nov 2011 | |
placebo (Placebo) | ovxogidvbq(nnibgueigv) = aumwqeqddv yjvzixxkay (juqllvrogx, dfbnlfqdne - gzkwefybcl) View more | ||||||
Phase 1 | 64 | (V710 With MAA) | vrlglnbixa(cptpxcjejd) = cqqyvatprr tycfxmudhj (iokwgsplov, qrkchyhdda - ncobnfsrcr) View more | - | 17 Oct 2011 | ||
(V710 Without MAA) | vrlglnbixa(cptpxcjejd) = dwzghdvulp tycfxmudhj (iokwgsplov, jusejwxlsc - axdhmqvvao) View more | ||||||
Phase 1 | 124 | (V710 5 μg) | uadlhhbcbs(wfdtagsqpo) = zsdbxndrso nwczhtqdop (fdovolulws, jhhfklkygi - bfrbjozksq) View more | - | 20 Oct 2010 | ||
(V710 30 μg) | uadlhhbcbs(wfdtagsqpo) = mnjsihkjxo nwczhtqdop (fdovolulws, byhwbcurjm - gzstqjknqw) View more |